Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals (United States)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

60%


Total
Publications

981


Total Open
Publications

589


Total
Citations

34K


Open Access
Percentage

60%


Total
Publications

981


Total Open
Publications

589


Total
Citations

34K

Wikipedia

Website

download

Breakdown

23% 32% 5% 40%

Publisher Open

23%

Both

32%

Other Platform Open

5%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

179

Hybrid 36%

193

No Guarantees 31%

165

Other Platform Open

Domain 86%

315

Institution 27%

101

Other Internet 8%

28

Preprint 6%

23

Public 5%

17

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
311
Europe PMC
Domain
123
Ghent University - Ghent University Academic Bibliography
Institution
20
Radboud University - Radboud Repository
Institution
18
KU Leuven - Lirias
Institution
12
Semantic Scholar
Public
11
Research Square
Preprint
11
Figshare
Public
11
Erasmus University Rotterdam - EUR Research Repository
Institution
9
DOI
Other Internet
9
1 / 10

Data updated 13 February 2025

Share

Share

Share